WU Lin, LU Hong-lian. Efficacy and Safety of Tepotinib in Non-Small-Cell Lung Cancer With MET Exon 14 Skipping Mutations[J]. Journal of Evidence-Based Medicine, 2020, 20(5): 268-271. DOI: 10.12019/j.issn.1671-5144.2020.05.004
|
Citation:
|
WU Lin, LU Hong-lian. Efficacy and Safety of Tepotinib in Non-Small-Cell Lung Cancer With MET Exon 14 Skipping Mutations[J]. Journal of Evidence-Based Medicine, 2020, 20(5): 268-271. DOI: 10.12019/j.issn.1671-5144.2020.05.004
|
WU Lin, LU Hong-lian. Efficacy and Safety of Tepotinib in Non-Small-Cell Lung Cancer With MET Exon 14 Skipping Mutations[J]. Journal of Evidence-Based Medicine, 2020, 20(5): 268-271. DOI: 10.12019/j.issn.1671-5144.2020.05.004
|
Citation:
|
WU Lin, LU Hong-lian. Efficacy and Safety of Tepotinib in Non-Small-Cell Lung Cancer With MET Exon 14 Skipping Mutations[J]. Journal of Evidence-Based Medicine, 2020, 20(5): 268-271. DOI: 10.12019/j.issn.1671-5144.2020.05.004
|
DownLoad: